Related Experiment Video
Updated: Jun 30, 2026

Assessing the Effects of Music Listening on Psychobiological Stress in Daily Life
Published on: February 2, 2017
The sound and the fury: was it all worth it?
1Division of Epidemiology and Genetics, Epidemiology and Biostatistics Program, National Cancer Institute, Bethesda, Maryland 20892, USA. hooverr@mail.nih.gov
Insights
The Women's Health Initiative trial on menopausal hormone therapy revealed surprising coronary heart disease (CHD) results. Years of research clarified these findings, improving public health messaging on hormone therapy.
Area of Science:
- Epidemiology
- Cardiovascular Research
- Women's Health
Background:
- The Women's Health Initiative (WHI) trial initially reported unexpected coronary heart disease (CHD) risks associated with menopausal hormone therapy (MHT).
- These findings contrasted sharply with previous observational studies, creating significant debate within the medical and research communities.
- This discrepancy prompted extensive investigation into the differing results and methodologies.
Discussion:
- Intense scientific debate and methodologic research focused on reconciling the conflicting data between the WHI trial and observational studies.
- The discussion highlighted the importance of study design, patient populations, and confounding factors in epidemiological research.
- This period led to a deeper understanding of the complexities surrounding MHT and cardiovascular outcomes.
Key Insights:
- Significant advancements were made in methods for contrasting and combining data from studies with different designs (e.g., randomized controlled trials vs. observational studies).
- The controversy provided clear illustrations of fundamental epidemiological principles, such as bias, confounding, and effect modification.
- New insights emerged regarding the potential mechanisms by which MHT might influence CHD, considering factors like timing of initiation and formulation.
Outlook:
- The research has led to greater clarity in public health messaging regarding the risks and benefits of menopausal hormone therapy.
- Improved methodologies for evaluating complex medical interventions are now available.
- Future research will continue to refine our understanding of hormone therapy's impact on cardiovascular health in diverse populations.
Abstract:
The initial report of coronary heart disease (CHD) results from the trial of menopausal hormone therapy within the Women's Health Initiative precipitated substantial surprise and concern in the epidemiology research community over the apparent differences between the trial results and those of observational studies. What followed was 6 years of discussion and debate, frequently acrimonious, along with intense methodologic and substantive research attempting to reconcile or explain the apparent differences. The results have been an impressive improvement in methods to contrast and combine studies of differing designs, dramatic illustrations of some central epidemiologic principles, insights into likely mechanisms of CHD, and increasing clarity of the public health message about menopausal hormone therapy.
Related Concept Videos
The Stanford Prison Experiment
Milgram's Obedience to Authority
Robbers Cave
Sound as Pressure Waves
The pressure fluctuation depends on the difference in displacements between the successive points in the...
Intensity and Pressure of Sound Waves
Unlike the time average of a sinusoidal term, which is zero since it is positive and...
Hindsight Biases

